| Application no. and date | 05791482.2 (espacenet) (Federated) (European Patent Register), 20050826 | | Patent/reg. no. and date | DK/EP 1781802, 20091021 | | Publication date | 20070509 | | Priority no. and date | US 605379 P, 20040827 | | EP pub. no. and date |
EP 1781802 20070509 | | Effective date | | | Applicant/owner | Pfizer Ireland Pharmaceuticals, Operations Support Group
Ringaskiddy, County Cork, IE | | Applicant ref. no. | 137334 | | Inventor | DRAPEAU, Denis, 55 Old Farm Road
Salem, NH 03079, US,
LUAN, Yen-Tung, 3 Armand Drive
Chelmsford, MA 01824, US,
WANG, Wenge, 1 Hollowridge Road
North Chelmsford, MA 01863, US,
MERCER, James, R., 226 Hampstead Road
Derry, NH 03041, US,
LASKO, Daniel R., 19 Gleason Street
Medford, MA 02155, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C12N 15/62 (2006.01) , C12P 21/02 (2006.01) | | Title | Fremstilling af et TNFR-Ig-fusionsprotein | | Int. application no. | US2005030439 | | Int. publication no. | WO2006026447 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
